Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Castaño

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Brain Pathology (Zurich, Switzerland)|July 1, 1991
Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosisE M Castaño, B Frangione
Current Opinion in Neurology|August 1, 1995
Non-Alzheimer's disease amyloidoses of the nervous systemE M Castaño, B Frangione
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1988
Human amyloidosis, Alzheimer disease and related disordersE M Castaño, B Frangione
The Biochemical Journal|March 1, 1996
The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysisC Soto, E M Castaño
Current Opinion in Neurobiology|October 1, 1991
Inherited amyloids of the nervous systemE M Castaño, T Wisniewski, B Frangione
The American Journal of Pathology|December 1, 1987
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-proteinF Coria, E M Castaño, B Frangione
Medicina|January 1, 1987
[Amyloidosis of the central nervous system]E M Castaño, J A Ghiso, B Frangione
Cell and Tissue Research|November 26, 1999
Differential accumulation of soluble amyloid beta peptides 1-40 and 1-42 in human monocytic and neuroblastoma cell lines. Implications for cerebral amyloidogenesisL Morelli, M I Prat, E M Castaño
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1995
Apolipoprotein E and amyloidogenesisE M Castaño, F C Prelli, B Frangione
Neuroreport|February 29, 1996
Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitroC Soto, A Golabek, T Wisniewski, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Brain Pathology (Zurich, Switzerland)|July 1, 1991
Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosisE M Castaño, B Frangione
Current Opinion in Neurology|August 1, 1995
Non-Alzheimer's disease amyloidoses of the nervous systemE M Castaño, B Frangione
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1988
Human amyloidosis, Alzheimer disease and related disordersE M Castaño, B Frangione
The Biochemical Journal|March 1, 1996
The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysisC Soto, E M Castaño
Current Opinion in Neurobiology|October 1, 1991
Inherited amyloids of the nervous systemE M Castaño, T Wisniewski, B Frangione
The American Journal of Pathology|December 1, 1987
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-proteinF Coria, E M Castaño, B Frangione
Medicina|January 1, 1987
[Amyloidosis of the central nervous system]E M Castaño, J A Ghiso, B Frangione
Cell and Tissue Research|November 26, 1999
Differential accumulation of soluble amyloid beta peptides 1-40 and 1-42 in human monocytic and neuroblastoma cell lines. Implications for cerebral amyloidogenesisL Morelli, M I Prat, E M Castaño
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1995
Apolipoprotein E and amyloidogenesisE M Castaño, F C Prelli, B Frangione
Neuroreport|February 29, 1996
Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitroC Soto, A Golabek, T Wisniewski, et al.
Pageof 4